Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 134,986 251,929 319,053 656,089
Total Sell Value $11,097,511 $21,508,551 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 9 19 27 56
End Date 2024-04-07 2024-01-05 2023-07-07 2022-07-07

   
Records found: 1285
  Page 45 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Grey Michael G Director   –       •      –    2015-11-16 4 OE $38.59 $289,425 D/D 7,500 33,750     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2015-11-16 4 AS $104.30 $2,085,918 D/D (20,000) 28,229     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2015-11-16 4 OE $39.06 $781,200 D/D 20,000 48,229     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2015-11-02 4 AS $117.56 $3,057 D/D (26) 35,605     -
   Davis George Eric SVP, General Counsel   •       –      –    2015-10-31 5 A $51.26 $923 D/D 18 65,994     -
   Mueller Brian VP, Corporate Controller   •       –      –    2015-10-31 5 A $51.26 $6,510 D/D 127 12,053     -
   Baffi Robert EVP, Technical Operations   •       –      –    2015-10-31 5 A $51.26 $1,333 D/D 26 97,026     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2015-10-31 5 A $51.26 $11,022 D/D 215 28,444     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2015-10-30 4 A $57.26 $1,489 D/D 26 35,631     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-10-15 4 AS $108.24 $108,241 I/I (1,000) 26,758     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-09-14 4 AS $131.43 $131,432 I/I (1,000) 27,758     -
   Heron Elaine J Director   –       •      –    2015-09-08 4 OE $21.51 $322,650 D/D 15,000 35,625     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-08-12 4 AS $134.72 $202,083 I/I (1,500) 28,758     -
   Davis George Eric SVP, General Counsel   •       –      –    2015-07-24 5 GD $0.00 $0 D/D 105 65,976     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2015-07-20 4 AS $150.00 $450,000 D/D (3,000) 35,605     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2015-07-20 4 OE $63.10 $189,300 D/D 3,000 38,605     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-07-07 4 S $139.07 $208,600 I/I (1,500) 30,258     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-07-02 4 GD $0.00 $0 D/D 500 228,754     -
   Young William D Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 1,100 11,875     -
   Slamon Dennis Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 1,100 6,325     -
   Meier Richard A Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 1,100 25,250     -
   Lewis Alan Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 1,100 22,500     -
   Lawlis V Bryan Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 1,100 12,900     -
   Grey Michael G Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 1,100 26,250     -
   Lapalme Pierre Director   –       •      –    2015-06-10 4 A $0.00 $0 D/D 1,100 31,250     -

  1285 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 45 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed